Showing results (251-260 of 303) with videos related to

Sort By:
Pageof 31
The New England Journal of Medicine|July 13, 2012
Clinical and biomarker changes in dominantly inherited Alzheimer's diseaseRandall J Bateman, Chengjie Xiong, Tammie L S Benzinger, et al.
Complex Psychiatry|March 10, 2025
Clinical, Genomic, and Neurophysiological Correlates of Lifetime Suicide Attempts among Individuals with an Alcohol Use DisorderPeter B Barr, Zoe Neale, Chris Chatzinakos, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Clinical, genomic, and neurophysiological correlates of lifetime suicide attempts among individuals with an alcohol use disorderPeter B Barr, Zoe Neale, Chris Chatzinakos, et al.
Nature|September 4, 2020
The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer's diseaseJi-Yeun Hur, Georgia R Frost, Xianzhong Wu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN)Andrew J Aschenbrenner, Bryan D James, Eric McDade, et al.
Translational Psychiatry|October 6, 2023
COVID-19 pandemic stressors are associated with reported increases in frequency of drunkenness among individuals with a history of alcohol use disorderJacquelyn L Meyers, Vivia V McCutcheon, Kristina A Horne-Osipenko, et al.
American Journal of Human Genetics|December 31, 2005
A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer diseaseAndrew Grupe, Yonghong Li, Charles Rowland, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2025
CASP8 intronic expansion identified by poly-glycine-arginine pathology increases Alzheimer's disease riskLien Nguyen, Ramadan Ajredini, Shu Guo, et al.
Annals of Neurology|March 27, 2016
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer networkSeonjoo Lee, Fawad Viqar, Molly E Zimmerman, et al.
Human Molecular Genetics|July 17, 2014
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's diseaseAlfredo Ramirez, Wiesje M van der Flier, Christine Herold, et al.
Pageof 31